No photo of Carolyn F. Deacon
  • Source: Scopus
1995 …2024

Research activity per year

Personal profile

Short presentation

Carolyn Deacon’s research interests centre on the degradation and metabolism of the entero-pancreatic hormones (GLP-1, GLP-2, GIP, PYY, glucagon), the physiology and pathophysiology of the incretin hormones, and the therapeutic applications of the incretin hormones, GLP-1 analogues and DPP-4 inhibitors in the treatment of type 2 diabetes.  In particular, early studies investigating the metabolic stability of GLP-1, originating from her laboratory in the mid-1990s, have been instrumental in establishing the principle of using DPP-4 inhibition as a novel antihyperglycaemic therapy.

CV

Academic Qualifications

  • 1979: B.Sc. (Zoology); University of Sheffield, UK
  • 1983: Ph.d.: University of Sheffield, UK
  • 1999: D.M.Sc.; Faculty of Health Sciences, University of Copenhagen, Denmark

 

Appointments

  • 1979-1982: Patrick and Irwin Packington Research Fellow in Zoology; University of Sheffield, UK
  • 1983-1986: Post-doctoral Research Associate; Max-Planck-Gesellschaft, Göttingen, Germany
  • 1987-1993: Post-doctoral Research Associate; University of Sheffield, UK
  • 1993-1995: Marie Curie Fellow; University of Copenhagen, Denmark
  • 1995-1998: Assistant Research Professor; University of Copenhagen, Denmark
  • 1998-1999: Temporary Lecturer; University of Copenhagen, Denmark
  • 2000- til nu: Associate Professor, University of Copenhagen, Denmark

Keywords

  • Faculty of Health and Medical Sciences
  • Type 2 diabetes
  • Incretin hormones
  • DPP-4 inhibitors

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or